TGFB1 and cystic fibrosis: In addition, molecular pathways, such as the transforming growth factor-β1 (TGF-β1) pathway associated with the activation and proliferation of cardiac fibroblasts, play a driving role in pathological ventricular remodeling and can be representative targets for the CF treatment.